{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:38:16Z","timestamp":1777955896968,"version":"3.51.4"},"reference-count":85,"publisher":"Elsevier","isbn-type":[{"value":"9780443430114","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.pbr.2025.08.008","type":"book-chapter","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:13:20Z","timestamp":1756120400000},"page":"131-153","source":"Crossref","is-referenced-by-count":1,"title":["Biomarkers: From early detection to treatment personalization"],"prefix":"10.1016","author":[{"given":"Saman","family":"Fatima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakshi","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Naved","family":"Quadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Z.","family":"Abdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neumar.2024.100034","article-title":"The role of machine learning in discovering biomarkers and predicting treatment strategies for neurodegenerative diseases: a narrative review","volume":"2","author":"Aborode","year":"2025","journal-title":"NeuroMarkers"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib2","first-page":"1","article-title":"Amyloid solutions: lecanemab, gantenerumab, and donanemab in the treatment of Alzheimer\u2019s disease","volume":"61","author":"Ali","year":"2025","journal-title":"Egypt. J. Neurology, Psychiatry Neurosurg."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-025-02317-8","article-title":"The potential of cfDNA as biomarker: opportunities and challenges for neurodegenerative diseases","volume":"75","author":"Ayd\u0131n","year":"2025","journal-title":"J. Mol. Neurosci."},{"issue":"11","key":"10.1016\/bs.pbr.2025.08.008_bib4","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/cells11111744","article-title":"Artificial intelligence and circulating cell-free DNA methylation profiling: mechanism and detection of Alzheimer\u2019s disease","volume":"11","author":"Bahado-Singh","year":"2022","journal-title":"Cells"},{"key":"10.1016\/bs.pbr.2025.08.008_bib5","article-title":"A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches","author":"Bai\u00e3o","year":"2025","journal-title":"arXiv Preprint"},{"key":"10.1016\/bs.pbr.2025.08.008_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2025.100071","article-title":"Unveiling somal biomarkers in neurodegenerative diseases: LC-MS-based profiling","volume":"5","author":"Bi","year":"2025","journal-title":"Extracell. Vesicle"},{"issue":"19_part_2","key":"10.1016\/bs.pbr.2025.08.008_bib7","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/01.wnl.0000311445.21321.fc","article-title":"CSF biomarkers in frontotemporal lobar degeneration with known pathology","volume":"70","author":"Bian","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2025.08.008_bib8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3233\/JAD-170773","article-title":"The past and future of Alzheimer\u2019s disease fluid biomarkers","volume":"62","author":"Blennow","year":"2018","journal-title":"J. Alzehimers Dis."},{"issue":"11","key":"10.1016\/bs.pbr.2025.08.008_bib9","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","article-title":"Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy","volume":"77","author":"Brendel","year":"2020","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib10","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1038\/s41467-023-42596-6","article-title":"Plasma biomarkers predict Alzheimer\u2019s disease before clinical onset in Chinese cohorts","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.008_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.008_bib12","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/s24051572","article-title":"Machine learning and digital biomarkers can detect early stages of neurodegenerative diseases","volume":"24","author":"Chudzik","year":"2024","journal-title":"Sensors"},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.008_bib13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/alz.12233","article-title":"ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration","volume":"17","author":"Cousins","year":"2021","journal-title":"Alzheimer\u2019s Dement"},{"issue":"7","key":"10.1016\/bs.pbr.2025.08.008_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","article-title":"Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer\u2019s disease therapeutics","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.008_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/STROKEAHA.117.018943","article-title":"Carotid intima-media thickness is associated with White matter hyperintensities: the Northern manhattan study","volume":"49","author":"Della-Morte","year":"2018","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib16","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1038\/s41598-025-95852-8","article-title":"Association of the digital clock drawing test with amyloid and tau PET biomarkers in low age risk adults","volume":"15","author":"Ding","year":"2025","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.008_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/17582024.2024.2402216","article-title":"Tofersen for SOD1 ALS","volume":"14","author":"Everett","year":"2024","journal-title":"Neurodegener. Dis. Manag."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.008_bib18","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1007\/s12035-024-04617-3","article-title":"Integration of single-cell and spatial transcriptomic data reveals spatial architecture and potential biomarkers in Alzheimer\u2019s disease","volume":"62","author":"Fan","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/bs.pbr.2025.08.008_bib19","doi-asserted-by":"crossref","unstructured":"Farag, M., Murphy, M.J., Fayer, K., Thackeray, O., Scahill, R.I., Hobbs, N.Z., et al., 2024. D020 Cerebrospinal fluid neurofilament light as a sensitive biomarker for early neurobiological changes in HD-ISS Stages 0 and 1: insights from the Huntington\u2019s disease young adult study (HD-YAS).","DOI":"10.1136\/jnnp-2024-EHDN.94"},{"key":"10.1016\/bs.pbr.2025.08.008_bib20","unstructured":"FDA clears first blood test used in diagnosing Alzheimer\u2019s disease. News release. FDA; May 16, 2025. Accessed\u00a018 June 2025. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.008_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.008_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf136","article-title":"Deep learning in single-cell and spatial transcriptomics data analysis: advances and challenges from a data science perspective","volume":"26","author":"Ge","year":"2025","journal-title":"Brief. Bioinforma."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.008_bib23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/bcpt.14003","article-title":"A review on the new age methodologies for early detection of Alzheimer\u2019s and Parkinson\u2019s disease","volume":"134","author":"Ghosh","year":"2024","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13311-022-01201-2","article-title":"Disease-modifying therapies for Alzheimer\u2019s disease: more questions than answers","volume":"19","author":"Golde","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-023-00605-8","article-title":"Plasma phospho-tau in Alzheimer\u2019s disease: towards diagnostic and therapeutic trial applications","volume":"18","author":"Gonzalez-Ortiz","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/bs.pbr.2025.08.008_bib26","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.3390\/ijms21113743","article-title":"Urinary 8-OHdG as a biomarker for oxidative stress: a systematic literature review and meta-analysis","volume":"21","author":"Graille","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib27","first-page":"1","article-title":"MINDSETS: multi-omics integration with neuroimaging for dementia subtyping and effective temporal study","volume":"15","author":"Hassan","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2025.08.008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-015-0069-y","article-title":"The development of precision medicine in clinical practice","volume":"4","author":"He","year":"2015","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/bs.pbr.2025.08.008_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fnagi.2018.00305","article-title":"Recent advances in biomarkers for Parkinson\u2019s disease","volume":"10","author":"He","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/bs.pbr.2025.08.008_bib30","doi-asserted-by":"crossref","first-page":"1515981","DOI":"10.3389\/fneur.2024.1515981","article-title":"Unraveling Alzheimer\u2019s disease: insights from single-cell sequencing and spatial transcriptomic","volume":"15","author":"He","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/bs.pbr.2025.08.008_bib31","article-title":"Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer\u2019s disease","author":"Hu","year":"2024","journal-title":"Med"},{"issue":"6","key":"10.1016\/bs.pbr.2025.08.008_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/biology13060451","article-title":"The advancement and application of the single-cell transcriptome in biological and medical research","volume":"13","author":"Huang","year":"2024","journal-title":"Biology"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.008_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12152-022-09498-8","article-title":"Towards a governance framework for brain data","volume":"15","author":"Ienca","year":"2022","journal-title":"Neuroethics"},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.008_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/jpm15050171","article-title":"Oxidative stress biomarkers as preclinical markers of mild cognitive impairment: the impact of age and sex","volume":"15","author":"Ioannidou","year":"2025","journal-title":"J. Personalized Med."},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.008_bib35","article-title":"miR-519a-3p, found to regulate cellular prion protein during alzheimer\u2019s disease pathogenesis, as a biomarker of asymptomatic stages","volume":"1870","author":"J\u00e1come","year":"2024","journal-title":"Biochimica et. Biophysica Acta (BBA)-Molecular Basis Dis."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-025-01712-y","article-title":"Evaluating the diagnostic performance of six plasma biomarkers for alzheimer\u2019s disease and other neurodegenerative dementias in a large Chinese cohort","volume":"17","author":"Jiao","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"6","key":"10.1016\/bs.pbr.2025.08.008_bib37","article-title":"Revolutionizing neurology: the role of artificial intelligence in advancing diagnosis and treatment","volume":"16","author":"Kalani","year":"2024","journal-title":"Cureus"},{"issue":"15","key":"10.1016\/bs.pbr.2025.08.008_bib38","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.0b013e318232ac1a","article-title":"Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease","volume":"77","author":"Karlawish","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2025.08.008_bib39","first-page":"772","article-title":"Plasma lncRNA profiling identified BC200 and NEAT1 lncRNAs as potential blood-based biomarkers for late-onset Alzheimer\u2019s disease","volume":"21","author":"Khodayi","year":"2022","journal-title":"EXCLI J."},{"issue":"10","key":"10.1016\/bs.pbr.2025.08.008_bib40","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.29835","article-title":"Increased CSF DOPA decarboxylase correlates with lower DaT\u2010SPECT binding: analyses in biopark and PPMI cohorts","volume":"39","author":"Khosousi","year":"2024","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/bs.pbr.2025.08.008_bib41","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.3390\/ijms25105307","article-title":"Potential exosome biomarkers for Parkinson\u2019s disease diagnosis: a systematic review and meta-analysis","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/bs.pbr.2025.08.008_bib42","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.3390\/ijms252111406","article-title":"Integrative metabolome and proteome analysis of cerebrospinal fluid in Parkinson\u2019s disease","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.pbr.2025.08.008_bib43","doi-asserted-by":"crossref","first-page":"1069411","DOI":"10.3389\/fneur.2023.1069411","article-title":"Plasma biomarkers for diagnosis of Alzheimer\u2019s disease and prediction of cognitive decline in individuals with mild cognitive impairment","volume":"14","author":"Kivis\u00e4kk","year":"2023","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.008_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound\u2010B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol.: Off. J. Am. Neurological Assoc. Child. Neurology Soc."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-022-00296-z","article-title":"Advances in the development of new biomarkers for Alzheimer\u2019s disease","volume":"11","author":"Klyucherev","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/bs.pbr.2025.08.008_bib46","first-page":"19","article-title":"Global regulatory landscape of biosimilars: emerging and established market perspectives","author":"Krishnan","year":"2015","journal-title":"Biosimilars"},{"key":"10.1016\/bs.pbr.2025.08.008_bib47","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and preclinical characterization of [18 F] PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer\u2019s disease and other tauopathies","volume":"46","author":"Kroth","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.008_bib48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.12779\/dnd.2024.23.4.188","article-title":"Revolutionizing Alzheimer\u2019s diagnosis and management: the dawn of biomarker-based precision medicine","volume":"23","author":"Kwon","year":"2024","journal-title":"Dement. Neurocognitive Disord."},{"key":"10.1016\/bs.pbr.2025.08.008_bib49","article-title":"ScAtt: an attention based architecture to analyze Alzheimer\u2019s disease at cell type level from single-cell RNA-sequencing data","author":"Liu","year":"2024","journal-title":"arXiv Preprint"},{"issue":"7","key":"10.1016\/bs.pbr.2025.08.008_bib50","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/ijms26073419","article-title":"Advancing personalized Medicine in alzheimer\u2019s disease: liquid biopsy epigenomics unveil APOE \u03b54-Linked methylation signatures","volume":"26","author":"Mac\u00edas","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.pbr.2025.08.008_bib51","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.neurobiolaging.2011.09.004","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: plasma A\u03b240 and A\u03b242, and genetic variants","volume":"32","author":"Mayeux","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.pbr.2025.08.008_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymeth.2020.02.002","article-title":"Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluids","volume":"177","author":"Muraoka","year":"2020","journal-title":"Methods"},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.008_bib53","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/ijms26052231","article-title":"Molecular biomarkers in neurological diseases: advances in diagnosis and prognosis","volume":"26","author":"Myrou","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.008_bib54","doi-asserted-by":"crossref","first-page":"729","DOI":"10.14283\/jpad.2023.111","article-title":"The critical role of biomarkers for drug development targeting the biology of aging","volume":"10","author":"Owen","year":"2023","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"10.1016\/bs.pbr.2025.08.008_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104646","article-title":"Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional study","volume":"93","author":"Parkin","year":"2023","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/bs.pbr.2025.08.008_bib56","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","article-title":"DOPA decarboxylase is an emerging biomarker for parkinsonian disorders including preclinical lewy body disease","volume":"3","author":"Pereira","year":"2023","journal-title":"Nat. Aging"},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.008_bib57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.pbr.2025.08.008_bib58","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/jpm14111104","article-title":"Considering biomarkers of neurodegeneration in Alzheimer\u2019s disease: the potential of circulating cell-free DNA in precision neurology","volume":"14","author":"Pollard","year":"2024","journal-title":"J. Personalized Med."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/acschemneuro.7b00304","article-title":"Single cell neurometabolomics","volume":"9","author":"Qi","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"19","key":"10.1016\/bs.pbr.2025.08.008_bib60","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/WNL.0000000000207757","article-title":"Antiamyloid monoclonal antibody therapy for alzheimer disease: emerging issues in neurology","volume":"101","author":"Ramanan","year":"2023","journal-title":"Neurology"},{"issue":"7871","key":"10.1016\/bs.pbr.2025.08.008_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.008_bib62","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/1354750X.2024.2342016","article-title":"Biomarker-guided drug development provides value for patients, payers and drug developers: lessons learned from 25 years in the biomarker industry","volume":"29","author":"Reese-Petersen","year":"2024","journal-title":"Biomarkers"},{"key":"10.1016\/bs.pbr.2025.08.008_bib63","first-page":"1","article-title":"AI for the prediction of early stages of Alzheimer\u2019s disease from neuroimaging biomarkers\u2013a narrative review of a growing field","author":"Rudroff","year":"2024","journal-title":"Neurological Sci."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","article-title":"Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early parkinson\u2019s disease","volume":"147","author":"Rutledge","year":"2024","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.008_bib65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/ph18040524","article-title":"Elucidating the synergistic effect of the PrimeC combination for amyotrophic lateral sclerosis in human induced pluripotent stem Cell-Derived motor neurons and mouse models","volume":"18","author":"Salomon-Zimri","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/bs.pbr.2025.08.008_bib66","article-title":"Parkinson\u2019s disease detection through vocal biomarkers and advanced machine learning algorithms","author":"Sayed","year":"2023","journal-title":"arXiv Preprint"},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.008_bib67","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/genes15040496","article-title":"Neurofilaments in sporadic and familial amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"15","author":"Shahim","year":"2024","journal-title":"Genes"},{"key":"10.1016\/bs.pbr.2025.08.008_bib68","series-title":"StatPearls [Internet]","article-title":"Pramipexole [Internet]","author":"Singh","year":"2023"},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.008_bib69","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"23","author":"Steinmetz","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/bs.pbr.2025.08.008_bib70","article-title":"SGUQ: staged graph convolution neural network for Alzheimer\u2019s disease diagnosis using multi-omics data","author":"Tao","year":"2024","journal-title":"ArXiv"},{"issue":"10","key":"10.1016\/bs.pbr.2025.08.008_bib71","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1002\/alz.14129","article-title":"Data sharing as the foundation of discovery: ADNI and breakthroughs in Alzheimer\u2019s disease","volume":"20","author":"Travaglia","year":"2024","journal-title":"Alzheimer\u2019s & Dement"},{"key":"10.1016\/bs.pbr.2025.08.008_bib72","unstructured":"US Food and Drug Administration, 2 August 2018. Qualifying a biomarker through the biomarker qualification program , FDA Website."},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.008_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/proteomes12030025","article-title":"Transforming clinical research: the power of high-throughput omics integration","volume":"12","author":"Vitorino","year":"2024","journal-title":"Proteomes"},{"key":"10.1016\/bs.pbr.2025.08.008_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.571437","article-title":"Differential circulating levels of naturally occurring antibody to \u03b1-uclein in Parkinson\u2019s disease dementia, Alzheimer\u2019s disease, and vascular dementia","volume":"12","author":"Wang","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/bs.pbr.2025.08.008_bib75","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020489","article-title":"Association of carotid intima\u2010media thickness and other carotid ultrasound features with incident dementia in the ARIC\u2010NCS","volume":"10","author":"Wang","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/bs.pbr.2025.08.008_bib76","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1002\/alz.13390","article-title":"Artificial intelligence for biomarker discovery in Alzheimer\u2019s disease and dementia","volume":"19","author":"Winchester","year":"2023","journal-title":"Alzheimer\u2019s & Dement"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","article-title":"Current and projected future economic burden of Parkinson\u2019s disease in the US","volume":"6","author":"Yang","year":"2020","journal-title":"npj Parkinson\u2019s Dis."},{"key":"10.1016\/bs.pbr.2025.08.008_bib78","first-page":"1","article-title":"Imaging biomarkers in neurodegeneration: current and future practices","volume":"12","author":"Young","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/bs.pbr.2025.08.008_bib79","first-page":"1","article-title":"Imaging biomarkers in neurodegeneration: current and future practices","volume":"12","author":"Young","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"01","key":"10.1016\/bs.pbr.2025.08.008_bib80","first-page":"19","article-title":"Translating biomarker discovery into clinical practice: challenges and opportunities","volume":"1","author":"Zafar","year":"2024","journal-title":"J. Transl. Res."},{"key":"10.1016\/bs.pbr.2025.08.008_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.125022","article-title":"MALDI mass spectrometry imaging discloses the decline of sulfoglycosphingolipid and glycerophosphoinositol species in the brain regions related to cognition in a mouse model of alzheimer\u2019s disease","volume":"266","author":"Zhang","year":"2024","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib82","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal. Transduct. Target. Ther"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.008_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14536","article-title":"Plasma p\u2010tau217 and p\u2010tau217\/A\u03b21\u201042 are effective biomarkers for identifying CSF\u2010and PET imaging\u2010diagnosed Alzheimer\u2019s disease: insights for research and clinical practice","volume":"21","author":"Zhong","year":"2025","journal-title":"Alzheimer\u2019s & Dement"},{"key":"10.1016\/bs.pbr.2025.08.008_bib84","first-page":"1","article-title":"An improved biomarker-guided adaptive patient enrichment design for oncology trials","author":"Zhou","year":"2025","journal-title":"J. Biopharmaceutical Stat."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.008_bib85","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s12967-024-05307-3","article-title":"Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Transl. Med."}],"container-title":["Progress in Brain Research","Precision Medicine in Neurodegenerative Diseases: From Research to Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612325001256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612325001256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:07:33Z","timestamp":1777939653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612325001256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443430114"],"references-count":85,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2025.08.008","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}